In the UK they are still giving two doses. Despite the fact the govts own research says having covid then having one dose (of Pfizer at least) is the same if not better as having never had covid and having two vaccine doses. The study mainly compared people who had never had covid and had one dose with people who had had covid and one dose, but also a few who had never had covid and had two doses. The results between the last two groups in terms of immune response were similar. This is probably why some countries are only giving one dose to people with confirmed previous covid infection.
www.gov.uk/government/news/new-study-finds-strong-immune-response-following-covid-19-vaccination
Key findings from the PITCH study
Among individuals who had not had COVID-19 in the past and had received 2 doses of the Pfizer vaccine, T cell response was as strong as people who had had previous COVID-19 infection and one vaccine dose.
After one dose of the Pfizer vaccine, individuals who had previous COVID-19 infection showed higher antibody and T cell responses compared with people who had not been infected before. Antibody responses were 6.8 times higher and T cell responses 5.9 times higher.
Among individuals who had not had COVID-19 in the past and had received one dose of the Pfizer vaccine, antibody and T cell responses were at a similar or higher level compared to those who had previously been infected but not been vaccinated.
There was a 10-fold greater spike-specific T cell responses following vaccination in people with previous infection compared to those who had no prior infection.
There was no link between age and levels of T cell/antibody response.
In this article on the BBC website www.bbc.co.uk/news/health-56538983 the main reason for still giving two doses is because lots of people think they had covid but didn't have it confirmed. So jab everyone to allow for the lowest common denominator of person who doesn't see the difference between thinking you've had it and knowing you've had it:
"These findings "inevitably" lead to debate about "whether vaccine supplies could be stretched further by offering only a single dose to those known to have been previously infected," said Prof Danny Altmann at Imperial College, London.
"For most of the world, including the UK, there may be sufficient diagnostic uncertainty as to who was definitely infected to make this approach hard to implement efficiently."